Skip to main content

U.S. Venture Partners — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

215
Companies
$2.6B
Total invested
$33.8M
Avg. check
52
Industries
Artificial Intelligence (AI) 8Software 7Health Care 7Biotechnology 6SaaS 5Developer APIs 4+46 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 215
BuyBuddy
September 2024

BuyBuddy is an IoT technology company that offers curated solutions for boosting offline conversion through physical engagements.

Analytics · KadikoySeed
Highlight Therapeutics
September 2025

Highlight Therapeutics is a clinical-stage biopharmaceutical company.

Biopharma · Paterna$17.8M Venture - Series Unknown
EmbodyX
September 2025

EmbodyX builds Physical AI that powers the industrial world

San Mateo$2.0M Pre-Seed
Artax Biopharma
August 2024

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

Biopharma · Cambridge$8.0M Convertible Note
Cricket Health
August 2021

Cricket Health is a specialty kidney care provider of integrated nephrology and dialysis care.

Health Care · San Francisco$83.5M Series B
Apollo.io
August 2023

Building the industry’s first fully agentic GTM platform, transforming how revenue teams execute

Artificial Intelligence (AI) · San FranciscoSeries D
Postman
August 2021

Postman is a software company that offers a platform for the users to design, develop, test, and organize custom APIs.

Developer APIs · San Francisco$225.0M Series D
Phyllo
August 2022

Universal APIs for social data & insights

Analytics · San Francisco$15.0M Series A
HyperTrack
August 2022

Location API for business automation

Developer APIs · San Francisco$25.0M Series A
Dynamo AI
August 2023

The enterprise platform for enabling private, secure, and regulation-compliant Gen AI models.

Artificial Intelligence (AI) · San FranciscoSeries A
Clean Crop Technologies
July 2026

Clean Crop Technologies specializes in advanced treatments for foods and seeds, effectively reducing mold, pathogens, and bacteria.

AgTech · Holyoke$7.9M Venture - Series Unknown
Rocketlane
July 2026

Rocketlane is a PSA platform that provides project management and collaboration services.

Collaboration · Wilmington$60.0M Venture - Series Unknown
NeRRe Therapeutics
July 2021

NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.

Biotechnology · Stevenage$27.6M Series B
Olto
July 2025

Olto crafts personalized live demos by overlaying AI-generated, prospect-relevant data on top of your existing production apps.

Artificial Intelligence (AI) · San Francisco$5.1M Pre-Seed
ToolJet
July 2023

ToolJet is a low-code open-source platform for developing and deploying custom business applications.

Developer APIs · San FranciscoVenture - Series Unknown
Minoryx Therapeutics
July 2025

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

Biotechnology · Barcelona$31.5M Grant
Ona Therapeutics
June 2026

Ona Therapeutics develops antibody-drug conjugates and therapies for the treatment of advanced and treatment-resistant cancers.

Biotechnology · Barcelona$86.6M Series B
Tolerance Bio
June 2026

Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.

Biotechnology · PhiladelphiaSeed
Pramaana Labs
June 2026

Pramaana Labs provides artificial intelligence systems that convert regulatory, legal, and technical text into machine-verifiable code.

Artificial Intelligence (AI) · San Francisco$27.0M Seed
TensorWave
June 2026

TensorWave is an AMD-exclusive cloud platform that leverages AMD Instinct GPUs and ROCm for high-performance AI workloads.

AI Infrastructure · Las Vegas$350.0M Series B
Liminal Custody
May 2022

Liminal is a custody & wallet infrastructure platform for institutions, empowering enterprises building on digital assets.

Asset Management · Singapore$4.7M Seed
Daloopa
May 2026

Daloopa provides comprehensive financial data to enhance investment research workflows and AI capabilities.

Analytics · New York$47.0M Series C
Triomics
May 2026

Triomics is a generative AI-powered platform that matches patients to clinical trials.

Artificial Intelligence (AI) · San FranciscoSeries B
Contrario
May 2026

Contrario is an entirely autonomous recruiting agency that operates on the basis of advanced artificial intelligence technology.

Artificial Intelligence (AI) · San Francisco$500K Seed

Where U.S. Venture Partners invests

Artificial Intelligence (AI)8
Software7
Health Care7
Biotechnology6
SaaS5
Developer APIs4

About U.S. Venture Partners's portfolio

How many companies has U.S. Venture Partners invested in?

U.S. Venture Partners has invested in 215 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does U.S. Venture Partners invest in?

U.S. Venture Partners's top investment sectors include Artificial Intelligence (AI), Software, Health Care, Biotechnology, SaaS. The firm invests across 52 different industry categories.

What is U.S. Venture Partners's largest investment?

Among tracked funding rounds, TensorWave received $350.0M in a Series B round. U.S. Venture Partners's total known invested capital is $2.6B.

What is the average investment size for U.S. Venture Partners?

U.S. Venture Partners's average investment size is $33.8M across its portfolio of 215 companies.

What are U.S. Venture Partners's most recent investments?

Recent U.S. Venture Partners portfolio additions include BuyBuddy, Highlight Therapeutics, EmbodyX, Artax Biopharma, Cricket Health. These companies were founded in 2020 or later.

Reach the founders behind these 215 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →